Your browser doesn't support javascript.
loading
A Needs Assessment of Persons With Sickle Cell Disease in a Major Medical Center in North Carolina.
Masese, Rita V; Crego, Nancy; Douglas, Christian; Rains, Gary; Bonnabeau, Emily; DeMartino, Terri; Shah, Nirmish; Tanabe, Paula.
Affiliation
  • Masese RV; School of Nursing, Duke University, Durham, North Carolina. rita.masese@duke.edu.
  • Crego N; School of Nursing, Duke University, Durham, North Carolina.
  • Douglas C; School of Nursing, Duke University, Durham, North Carolina.
  • Rains G; Duke Office of Clinical Research, Duke University School of Medicine, Durham, North Carolina.
  • Bonnabeau E; School of Nursing, Duke University, Durham, North Carolina.
  • DeMartino T; School of Nursing, Duke University, Durham, North Carolina.
  • Shah N; Duke University Medical Center, Duke Health, Durham, North Carolina.
  • Tanabe P; School of Nursing, Duke University, Durham, North Carolina.
N C Med J ; 82(5): 312-320, 2021.
Article in En | MEDLINE | ID: mdl-34544765
ABSTRACT
BACKGROUND Sickle cell disease (SCD) is a complex disease associated with many complications and a shortened lifespan. In 2016, the National Heart, Lung and Blood Institute funded 8 centers in the United States to form the Sickle Cell Disease Implementation Consortium, with the goal of improving SCD care. The aim of our study was to describe SCD self-efficacy, pain interference, and barriers to care from the perspective of persons with SCD in the North Carolina center.METHODS Persons with SCD, aged 15 and older were recruited from a large SCD center in North Carolina. Surveys, focus groups, and interviews were completed.RESULTS Fifty-one people completed a survey, and 14 people completed an interview or focus group. Barriers identified in the survey included self-care barriers, misconceptions related to hydroxyurea (an oral medication that reduces rates of pain crisis), limited provider knowledge, and stigma. Concerning self-efficacy, participants reported that they were able to manage their pain symptoms most of the time. Pain interfered most with the ability to participate in social and day-to-day activities.Common themes from the focus groups and interviews included misconceptions about hydroxyurea, pain, provider knowledge, stigma, co-management, transportation, and insurance. Recommendations to improve care included the use of case managers, utilization of treatment guidelines, individualized pain protocols, and effective co-management by providers.LIMITATIONS Participants were recruited from 1 SCD center and may not be representative of the entire SCD population in North Carolina.CONCLUSIONS Participants described many perceived barriers to care, and their responses suggest a need for improvements in patient hydroxyurea education, provider knowledge, and care coordination.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anemia, Sickle Cell Type of study: Guideline / Qualitative_research Limits: Humans Country/Region as subject: America do norte Language: En Journal: N C Med J Year: 2021 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anemia, Sickle Cell Type of study: Guideline / Qualitative_research Limits: Humans Country/Region as subject: America do norte Language: En Journal: N C Med J Year: 2021 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA